Dr Rachel Bayley, a Research Fellow within the Institute of Cancer and Genomic Sciences.
Dr Archana Sharma-Oates reports on the 'Ethnic Diversity in Cancer Genomics' workshop, funded by MRC Proximity to Discovery and facilitated by the UoB India Institute, that took place on 30 January 2018, bringing together scientists and clinicians from India, Africa and the UK.
Professor Pamela Kearns, Director of the Cancer Research UK Clinical Trials Unit, writes for the Birmingham Brief on how current innovations in cancer medicines are not reaching children.
Scientists at the University of Birmingham are set to receive a major cash boost for pioneering research into cancer.
Patients having surgery in low income countries are more likely to develop an infection than those in wealthier nations.
A patient who was given only 12 months to live four years ago has teamed up with his consultant to help launch a national campaign for Cancer Research UK.
A new nanopore technology for direct sequencing of long strands of DNA has resulted in the most complete human genome ever assembled with a single technology, scientists have revealed.
The Paediatric Hepatic International Tumour Trial (PHITT), which opened in August 2017, is continuing to recruitment patients, with eight registered to date. PHITT, which is being coordinated by the University of Birmingham's Cancer Research UK Clinical Trials Unit, will be operating in 13 European countries and aims to recruit 300 patients.
A trial designed and co-ordinated by the Cancer Research UK Clinical Trials Unit to test an experimental drug in patients with head and neck cancer has launched today through the Combinations Alliance.
Cancer Research UK has awarded the University of Birmingham £1.5 million to fund a five-year research programme aimed at finding new treatments for bowel cancer.